The data gap in women’s health has always been a major issue and challenge. Ridhi Tariyal, CEO and co-founder of NextGen Jane, is on a mission to de-risk the women’s health field and fill in the blanks with critical information and research. Host Swaril Mathur speaks with Tariyal on how NextGen Jane is collecting data through menstrual blood to make diagnoses and treatments easier. Tariyal also shares advice on the pros and cons of going the cash-pay consumer route and pitching the right business proposal to gain investors’ attention, as well as NextGen’s plans and focus points. 

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare  

MicroTransponderLinks:
MicroTransponder 

NextGen Jane: 
NextGen Jane 

From consulting to working at large companies to taking a risk with start-ups to becoming Silk Road Medical’s CEO, Chas McKhann has experienced almost everything in his long and illustrious career. In a discussion with Medtech Talk host Geoff Pardo, McKhann shares all the lessons learned from his jump to small private companies, handling a cultural rebirth as a newcomer CEO under the public eye, and taking on his role at Silk Road. He also talks about the “what if’s” of his journey and tips on surviving in the industry, as well as witnessing the market shift from only caring about revenue to wanting to see the path to capital break even. 

LINKS:
Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare  

Silk Road Medical: 
Silk Road Medical 

Niche markets and small populations don’t get the attention they need for medtech and healthcare.  Medtech Talk host Swaril Mathur speaks with Eric Chehab, founder and former CEO of Novonate and director of business development of Laborie OB/GYN/NICU, and James Wall, pediatric surgeon and founder of Impact1 at Stanford University, about how they’re bringing medtech innovation to small patient populations. They delve into their experiences of founding their own niche market companies and the lessons learned, including how they navigated commercialization and acquisition processes, convinced the right investors, determined capital efficiency, and more. They also share their thoughts on investors who think niche solutions for niche markets are uninteresting. 

Medtech Talk Links:  
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare 
MicroTransponderLinks:
MicroTransponder
Stanford University Links:
Stanford Healthcare
Stanford Medicine Children’s Health
Stanford University 

Laborie Links:
Laborie 

Live from Medtech MVP, Michael Mahoney, chairman and CEO of Boston Scientific Corp, sits down with Medtech Talk podcast host Justin Klein. They discuss Mahoney’s communications strategies to align expectations and convey intentions to shareholders, how to delegate and streamline decision making, and advice on doing better as a partner. Mahoney also shares which second order considerations (such as manufacturing) are important to keep in mind, as well as whether he’s a “war time” or “peace time” CEO and what challenges the industry needs to address today to create a better tomorrow. 

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare  

Boston Scientific Corp: 
Boston Scientific Corp 

In this episode of Medtech Talk, host Geoff Pardo and Eric Wichems, former CEO of Vertos Medical (recently acquired by Stryker), discuss the responsibilities of a CEO, why high accountability and transparency are important aspects of company culture, and how to hire the right person for the position—and how to determine if they can thrive in your company’s culture. Wichems shares his background in engineering and how he found his way to Vertos, as well as his thoughts on the Stryker acquisition and the reasons behind it. 

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare   

Vertos Medical:
Vertos Medical 

Stryker:
Stryker Interventional Spine 

In this month’s Medtech Talk, co-host Swaril Mathur, vice president of business development at Axonics, debuts in her first episode with John Woock, former EVP and chief marketing and strategy officer at Axonics. They discuss the early days of their company, including what motivated Woock to join a company that was considered risky at the time, what he learned from supporting and working directly with the field team, and how Axonics handled the early stages of commercial launch during the pandemic. Woock also reflects on how much the company has changed over the years in its culture and leadership, including the decisions that felt good and the ones that were harder to grapple with. 

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare   

Axonics Links: 
Axonics 

This month at Medtech Talk, co-host Justin Klein, co-founder and managing partner at Vensana Capital, debuts in his first episode with a discussion with Douglas Kelly, former deputy center director for science and chief scientist at the Center for Devices and Radiological Health at the FDA. Kelly talks about his time at the FDA and the fundamental changes he implemented to make a helpful impact on patients, including when the pandemic was at its peak. Kelly also shares his thoughts on the value of fostering innovation and the importance of breakthrough designation, as well as how to approach the process of advocacy and get in better alignment with shared priorities with the FDA, CMS, and other stakeholders

In the first Medtech Talk episode of 2025, host Geoff Pardo speaks with Dr. Billy Cohn, MD, PhD (H), Chief Medical Officer of BiVACOR, about entrepreneurship, limitless innovation, and thinking outside the box. Dr. Cohn discusses his experiences as a driving force behind the Center for Device Innovation at the Texas Medical Center, what influenced him to pursue medical devices, and finding resources in everyday objects. He also provides advice for budding entrepreneurs and engineers and why he believes Home Depot is the headquarters of medical device prototyping. 

In this episode of Medtech Talk, host Geoff Pardo speaks with Michael Jaff, DO, chief medical officer and vice president of Clinical Affairs, Technology, and Innovation at Boston Scientific. Dr. Jaff has a long list of achievements and a robust background as a professor of Medicine at Harvard Medical School, president of Newton-Wellesley Hospital, medical director at the Massachusetts General Hospital, and more. Dr. Jaff shares his thoughts on good leadership, medical device innovation (and how they can help hospitals succeed), and how hospitals and manufacturers can navigate post-COVID-19 financial strains. He also discusses his journey from clinician to hospital CEO to the manufacturing industry, as well as Boston Scientific’s outlook on the future.  

Medtech Talk Links:  
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare  

Boston Scientific:
Boston Scientific 

In this episode of Medtech Talk, host Geoff Pardo and Per Langoe, CEO of GT Medical, discuss Langoe’s extensive career, from his start in sales to eventually making his way to medtech. Langoe gives tips on how to keep investors on board during times of crisis (such as the Covid-19 pandemic) and how he hires the right people for the job, as well as the differences between small companies and big companies and owning your company versus selling it to a larger company. He also shares what attracted him to GT Medical, what the company’s future looks like, and more. Thanks to Silicon Valley Bank for hosting this episode.

Medtech Talk Links:  
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare  

GT Medical:
GT Medical 

GammaTile:
GammaTile